Zinc transporter 8 autoantibody in the diagnosis of type 1 diabetes in children

다국어 초록 (Multilingual Abstract)

Background: Type 1 diabetes (T1D) is an organ-specific autoimmune disease related to the autoimmune response against pancreatic β-cells. Zinc transporter 8 (ZnT8), an islet-specific gene product localized to the β-cell insulin granule, was recently identified as an autoantigen in T1D.Purpose: To evaluate the use of ZnT8 autoantibody (ZnT8A) for diagnosing T1D.Methods: This case-control study was conducted at Dr. Soetomo General Hospital, Surabaya, Indonesia, from March to May 2019. Children younger than 18 years of age with T1D based on the International Society for Pediatric and Adolescent Diabetes guideline and healthy controls were included. We measured ZnT8A level using enzyme-linked immunosorbent assay (cutoff value, 0.315).Results: There were 30 children with T1D (50.0% boys; mean age, 11.3±3.7 years) and 18 healthy controls (44.4% boys; mean age, 8.3±3.1 years); 1 patient in each group was Madurese, while the others were Javanese. Twenty-two of 30 subjects with T1D (73.3%) tested positive for ZnT8A compared to 5 of 18 controls (27.8%) (<i>P</i>=0.02; odds ratio, 7.15; 95% confidence interval, 1.93–26.52). When ZnT8A-positive and -negative T1D cases were compared, no differences were detected in age at diagnosis, duration of diabetes, presence of ketoacidosis, body mass index, glycosylated hemoglobin concentration, or C-peptide concentrations.Conclusion: ZnT8A may be useful in the diagnosis of T1D.

참고문헌 (Reference)

1 Vaziri-Sani F, "ZnT8 autoantibody titers in type 1 diabetes patients decline rapidly after clinical onset" 43 : 598-606, 2010

2 Araujo DB, "Zinc transporter 8 autoantibodies in patients with type 1 diabetes from a multiethnic population and their first degree relatives" 58 : 737-743, 2014

3 Kawasaki E, "Zinc transporter 8 autoantibodies in fulminant, acute-onset, and slow-onset patients with type 1 diabetes" 27 : 895-898, 2011

4 Delli AJ, "Zinc transporter 8 autoantibodies and their association with SLC30A8 and HLA-DQ genes differ between immigrant and Swedish patients with newly diagnosed type 1 diabetes in the Better Diabetes Diagnosis study" 61 : 2556-2564, 2012

5 Petruzelkova L, "The dynamic changes of zinc transporter 8 autoantibodies in Czech children from the onset of Type 1 diabetes mellitus" 31 : 165-171, 2014

6 Yang L, "The diagnostic value of zinc transporter 8 autoantibody(ZnT8A)for type 1 diabetes in Chinese" 26 : 579-584, 2010

7 Wenzlau JM, "The cation efflux transporter ZnT8(Slc30A8)is a major autoantigen in human type 1diabetes" 104 : 17040-17045, 2007

8 Garnier L, "Screening of ZnT8 autoantibodies in the diagnosis of autoimmune diabetes in a large French cohort" 478 : 162-165, 2018

9 Gorus FK, "Screening for insulinoma antigen 2 and zinc transporter 8 autoantibodies : a cost-effective and age-independent strategy to identify rapid progressors to clinical onset among relatives of type 1 diabetic patients" 171 : 82-90, 2013

10 Elmaoğulları S, "Prevalence of ZnT8 antibody in turkish children and adolescents with new onset type 1 diabetes" 10 : 108-112, 2018

11 Juusola M, "Positivity for zinc transporter 8 autoantibodies at diagnosis is subsequently associated with reduced β-cell function and higher exogenous insulin requirement in children and adolescents with type 1diabetes" 39 : 118-121, 2016

12 Wenzlau JM, "Novel antigens in type 1 diabetes : the importance of ZnT8" 9 : 105-112, 2009

13 Mbanya A, "Metabolic features associated with positivity to ZnT8 autoantibody in sub-Saharan African young-onset diabetes patients" 42 : 204-206, 2016

14 Sharma A, "Identification of non-HLA genes associated with development of islet autoimmunity and type 1 diabetes in the prospective TEDDY cohort" 89 : 90-100, 2018

15 Craig ME, "ISPAD Clinical Practice Consensus Guidelines 2014. Definition, epidemiology, and classification of diabetes in children and adolescents" 15 (15): 4-17, 2014

16 Howson JM, "Genetic association of zinc transporter 8(ZnT8)autoantibodies in type 1 diabetes cases" 55 : 1978-1984, 2012

17 Kawasaki E, "Diagnostic criteria for acute-onset type 1 diabetes mellitus(2012) : Report of the Committee of Japan Diabetes Society on the Research of Fulminant and Acute-onset Type 1 Diabetes Mellitus" 5 : 115-118, 2014

18 Lampasona V, "Diabetes antibody standardization program : first proficiency evaluation of assays for autoantibodies to zinc transporter 8" 57 : 1693-1702, 2011

19 Trabucchi A, "Detection and characterization of ZnT8 autoantibodies could help to screen latent autoimmune diabetes in adult-onset patients with type 2 phenotype" 45 : 137-142, 2012

20 Unal I, "Defining an optimal cut-point value in ROC analysis : an alternative approach" 2017 : 3762651-, 2017

21 Yi B, "Current and future clinical applications of zinc transporter-8 in type 1 diabetes mellitus" 128 : 2387-2394, 2015

22 Vermeulen I, "Contribution of antibodies against IA-2β and zinc transporter 8 to classification of diabetes diagnosed under 40 years of age" 34 : 1760-1765, 2011

23 Faccinetti NI, "Characterization of zinc transporter 8(ZnT8)antibodies in autoimmune diabetic patients from Argentinian population using monomeric, homodimeric, and heterodimeric ZnT8 antigen variants" 174 : 157-165, 2016

24 Dunseath G, "Bridging-type enzyme-linked immunoassay for zinc transporter 8 autoantibody measurements in adult patients with diabetes mellitus" 447 : 90-95, 2015

25 Fabris M, "Anti-zinc transporter protein 8 autoantibodies significantly improve the diagnostic approach to type 1 diabetes : an Italian multicentre study on paediatric patients" 6 : 17-22, 2015

26 Wenzlau JM, "A common nonsynonymous single nucleotide polymorphism in the SLC30A8 gene determines ZnT8 autoantibody specificity in type 1diabetes" 57 : 2693-2697, 2008